What Is Driving Global Chronic Pain Market Growth in 2025: The Role of Risk Of Chronic Pain Patients Drives Growth In The Chronic Pain Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Chronic Pain Market Size Growth Forecast: What to Expect by 2025?
The size of the chronic pain sector has seen robust expansion over the past few years; projected figures indicate an increase from $78.79 billion in the year 2024 to reach $84.66 billion by 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. This historical upward trend is fundamentally driven by factors such as injuries and trauma, the volume of surgical interventions, various inflammatory disorders, the prevalence of nerve damage and neuropathy, and the persistent absence of sufficiently effective treatment modalities.

How Will the Chronic Pain Market Size Evolve and Grow by 2029?
Anticipation points toward substantial expansion within the chronic pain sector over the coming years, with the market valuation projected to reach $117.03 billion by 2029, reflecting a compounded annual growth rate of 8.4%. This upswing during the projection timeframe is underpinned by several factors, notably the advancing age of the general populace, the broadening reach of telemedicine services, heightened public consciousness regarding health matters, advancements in genetic research and personalized medical approaches, and the increasing impact of psychosocial pressures. Key developments shaping the market during this forecast period encompass the incorporation of wearable monitoring technology, the prominence of pain management educational initiatives and peer support networks, a shift towards comprehensive, holistic approaches to managing afflictions, increasing emphasis on alternatives to opioids for pain relief, and the utilization of regenerative medicine techniques in pain treatment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

What Drivers Are Propelling the Growth of Chronic Pain Market Forward?
The expanding population grappling with ongoing discomfort is anticipated to serve as a significant catalyst for the expansion of the chronic pain sector. These patients are defined as persons enduring pain that remains persistent or endures over an extended duration, usually surpassing three months, well past the expected recovery phase. This considerable number of individuals experiencing long-term suffering directly fuels the market for chronic pain treatments, as the escalating need for successful pain control methods, encompassing both medications and specialized equipment, fosters an environment ripe for new breakthroughs and industrial advancement. To illustrate this trend, data from the Australian Institute of Health and Welfare, an Australian governmental body, indicated in June 2024 that roughly 4.0 million Australians, equating to sixteen percent of the populace, were managing back issues during 2022; furthermore, by 2023, these back ailments had risen to become the third primary driver of the overall disease burden, accounting for 4.3% of the entire national burden. Complementing this, projections released in February 2024 by the Institute for Health Metrics and Evaluation, a US-based institution focusing on public health research both domestically and internationally, forecast that the worldwide incidence of neck pain would climb to an estimated 269 million cases by the year 2050 (with a predicted range between 219 and 322 million), marking a rise of 32.5% (spanning from 23.9% to 42.3%) from the figures recorded in 2020, thus clearly demonstrating that the sheer volume of chronic pain sufferers is propelling the chronic pain market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

Which Emerging Trends Are Transforming the Chronic Pain Market in 2025?
A significant emerging pattern within the chronic pain sphere involves alternative pain management technologies garnering increased adoption. To solidify their standing in this arena, businesses involved in treating chronic pain are concentrating efforts on creating novel, easily operable, and transportable nerve stimulation apparatuses; these function by delivering electrical signals to nerves to alleviate discomfort, thereby offering a non-surgical method for pain control. A prime illustration of this is Abbott Laboratories, an American healthcare firm with expertise across diagnostics, medical hardware, nutritional products, and branded generics, which introduced Eterna in December 2022; this represents the smallest, fully rechargeable, implantable spinal cord stimulation (SCS) system presently obtainable for chronic pain therapeutics. Utilizing Abbott's proprietary low-dose BurstDR stimulation-the only waveform technology supported by substantial clinical data (1A evidence)-the Eterna SCS system has shown a pain reduction superior by 23% when contrasted with treatments employing standard waveform approaches.

What Are the Key Segments in the Chronic Pain Market?
The chronic painmarket covered in this report is segmented -

1) By Product: Drug; Devices
2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
3) By End User: Hospitals; Clinics; Research Organization

Subsegments:
1) By Drug: Non-Opioid Analgesics; Opioids; Antidepressants; Anticonvulsants; Topical Analgesics; Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units; Spinal Cord Stimulators; Intrathecal Drug Delivery Systems; Heat And Cold Therapy Devices; Bioelectronic Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Who Are the Key Players Shaping the Chronic Pain Market's Competitive Landscape?
Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, dic*kinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

What Geographic Markets Are Powering Growth in the Chronic Pain Market?
North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.